AMB-051

N/A

Report date: 2026/04/17 20:02:02

Base Information

Drug NameAMB-051
Drug Alias NameAMB-05XAMB-051AMB 053AMB-055AMG-820
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionColony stimulating factor 1 receptor inhibitors
TargetsColony stimulating factor 1 receptor
Therapy Area/IndicationsSolid tumoursIdiopathic Pulmonary FibrosisCarcinoma, Non-Small-Cell Lung +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[10] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Texas MD Anderson Cancer CenterLifeMax Healthcare International CorpAmMax Bio Inc
Inactive CompaniesN/A
Active IndicationsTesticular NeoplasmsColorectal NeoplasmsSynovitis, Pigmented Villonodular +[4] 
Inactive IndicationsSolid tumoursIdiopathic Pulmonary FibrosisCarcinoma, Non-Small-Cell Lung +[5] 

Other Information

ATC CodeN/A
Related LinksN/A